Table 2.
Recent lipid nanoparticle delivery systems for mRNA-based vaccines.
Indication | Nanodelivery System Compositions | Route of Administration | In Vivo Model |
---|---|---|---|
Influenza virus | Ionizable lipid, DSPC, cholesterol, PEG lipid | Intramuscular | Rodents and NHPs |
Influenza virus | DOTAP, DOPE, (DSPE-Mpeg2000), Mannose | Intranasal | Mice |
COVID-19 | Ionizable lipid, DSPC, cholesterol, PEG lipid | Intramuscular | Mice and NHPs |
Respiratory syncytial virus | Ionizable lipid, DSPC, cholesterol, PEG lipid | Intramuscular | Mice and cotton rats |
NHPs; non-human primates.